{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:34:07Z","timestamp":1788449647564,"version":"build-2803163510"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Desmoplastic reaction is recognized as a prognostic factor in colorectal cancer. However, its significance in locally advanced rectal cancer after neoadjuvant chemoradiotherapy remains underexplored.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To assess the prognostic value of desmoplastic reaction in specimens from patients with advanced rectal cancer after chemoradiotherapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>This was a retrospective study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTINGS:<\/jats:title>\n            <jats:p>This study was conducted at a single comprehensive cancer center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>The study included 255 patients with advanced rectal cancer who underwent fluoropyrimidine-based chemoradiotherapy followed by total mesorectal excision from 2005 to 2014. Desmoplastic reaction was classified into mature, intermediate, and immature categories based on histological analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MAIN OUTCOME MEASURES:<\/jats:title>\n            <jats:p>The primary outcomes were recurrence-free survival and overall survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Desmoplastic reaction was classified as mature (69.0%), intermediate (5.5%), or immature (25.5%). The mature group had a higher percentage of good responders (34.1%) compared with the intermediate (0%) and immature (4.6%) groups (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001). The mature group correlated with better outcomes, with a higher 5-year recurrence-free survival (85.4%) and overall survival (93.0%) as compared with intermediate (45.1% and 76.2%, respectively) and immature (65.8% and 88.8%, respectively) groups. In the multivariable analysis, intermediate\/immature desmoplastic reaction was significantly associated with poorer recurrence-free survival (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.03). Among poor responders, intermediate\/immature desmoplastic reaction was associated with poorer recurrence-free survival (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.03). Adjuvant chemotherapy did not significantly improve the 5-year recurrence-free survival rate for the mature group (adjuvant chemotherapy vs no chemotherapy, 86.4% vs 84.8%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.64), with worse trends observed in the intermediate\/immature combined group (55.9% vs 69.4%, respectively, <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.27).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LIMITATIONS:<\/jats:title>\n            <jats:p>The limitations include the subjective nature of the desmoplastic reaction assessment and the retrospective design of the study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Desmoplastic reaction in surgical specimens after chemoradiotherapy is associated with responses to chemoradiotherapy and serves as a significant prognostic factor in advanced rectal cancer, particularly for those responding poorly to chemoradiotherapy. See <jats:bold>Video Abstract<\/jats:bold>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>IMPORTANCIA PRON\u00d3STICA DE LA REACCI\u00d3N DESMOPL\u00c1SICA TRAS LA QUIMIORRADIOTERAPIA NEOADYUVANTE EN EL C\u00c1NCER RECTAL AVANZADO<\/jats:title>\n            <jats:p>\n                                 <jats:bold>ANTECEDENTES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>La reacci\u00f3n desmopl\u00e1sica se reconoce como un factor pron\u00f3stico en el c\u00e1ncer colorrectal. Sin embargo, su importancia en el c\u00e1ncer rectal localmente avanzado despu\u00e9s de la quimiorradioterapia neoadyuvante sigue sin explorarse.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>OBJETIVO:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Evaluar el valor pron\u00f3stico de la reacci\u00f3n desmopl\u00e1sica en muestras de pacientes con c\u00e1ncer rectal avanzado despu\u00e9s de la quimiorradioterapia.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>DISE\u00d1O:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Este es un estudio retrospectivo.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>ESCENARIO:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Este estudio se llev\u00f3 a cabo en un solo centro oncol\u00f3gico integral.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>PACIENTES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>El estudio incluy\u00f3 a 255 pacientes con c\u00e1ncer rectal avanzado que se sometieron a quimiorradioterapia basada en fluoropirimidina seguida de una escisi\u00f3n mesorrectal total entre 2005 y 2014. La reacci\u00f3n desmopl\u00e1sica se clasific\u00f3 en categor\u00edas madura, intermedia e inmadura seg\u00fan el an\u00e1lisis histol\u00f3gico.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>RESULTADOS PRINCIPALES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Los resultados primarios fueron la supervivencia sin recurrencia y la supervivencia general. RESULTADOS: La reacci\u00f3n desmopl\u00e1sica se clasific\u00f3 como madura (69,0%), intermedia (5,5%) o inmadura (25,5%). El grupo maduro tuvo un mayor porcentaje de buenos respondedores (34,1%) en comparaci\u00f3n con los grupos intermedio (0%) e inmaduro (4,6%) (p &lt; 0,0001). El grupo maduro se correlacion\u00f3 con mejores resultados, con una mayor supervivencia libre de recurrencia a 5 a\u00f1os (85,4%) y supervivencia general (93,0%) en comparaci\u00f3n con los grupos intermedio (45,1% y 76,2%, respectivamente) e inmaduro (65,8% y 88,8%, respectivamente). En el an\u00e1lisis multivariable, la reacci\u00f3n desmopl\u00e1sica intermedia\/inmadura se asoci\u00f3 significativamente con una peor supervivencia libre de recurrencia (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0,03). Entre los malos respondedores, la reacci\u00f3n desmopl\u00e1sica intermedia\/inmadura se asoci\u00f3 con una peor supervivencia libre de recurrencia (p = 0,03). La quimioterapia adyuvante no mejor\u00f3 significativamente la tasa de supervivencia sin recurrencia a 5 a\u00f1os para el grupo maduro (quimioterapia adyuvante vs. ninguna quimioterapia, 86,4% vs. 84,8%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0,64), observ\u00e1ndose tendencias peores en el grupo combinado intermedio\/inmaduro (55,9% vs. 69,4%, respectivamente, <jats:italic toggle=\"yes\">p<\/jats:italic> = 0,27).<\/jats:p>\n            <jats:p>\n                                 <jats:bold>LIMITACIONES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Las limitaciones incluyen la naturaleza subjetiva de la evaluaci\u00f3n de la reacci\u00f3n desmopl\u00e1sica y el dise\u00f1o retrospectivo del estudio.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>CONCLUSIONES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>La reacci\u00f3n desmopl\u00e1sica en muestras quir\u00fargicas despu\u00e9s de la quimiorradioterapia se asocia con respuestas a la quimiorradioterapia y sirve como un factor pron\u00f3stico significativo en el c\u00e1ncer rectal avanzado, particularmente para aquellos que responden mal a la quimiorradioterapia. <jats:italic toggle=\"yes\">(Traducci\u00f3n\u2014Yesenia Rojas-Khalil<\/jats:italic>)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dcr.0000000000003589","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T15:00:30Z","timestamp":1733238030000},"page":"327-337","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Significance of Desmoplastic Reaction After Neoadjuvant Chemoradiotherapy in Advanced Rectal Cancer"],"prefix":"10.1097","volume":"68","author":[{"given":"Shuhei","family":"Sano","sequence":"first","affiliation":[{"name":"Department of Colorectal Surgery, Gastroenterological Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2321-1412","authenticated-orcid":false,"given":"Takashi","family":"Akiyoshi","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Gastroenterological Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Gastroenterological Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Gastroenterological Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimpei","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Gastroenterological Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Mukai","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Gastroenterological Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Gastroenterological Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Taketomi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery I, Graduate School of Medicine, Hokkaido University, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Gastroenterological Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Division of Clinical Research Planning and Strategy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kawachi","sequence":"additional","affiliation":[{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"R1-20250220","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1002\/ijc.32055","article-title":"Global trends in colorectal cancer mortality: projections to the year 2035.","volume":"144","author":"Araghi","year":"2019","journal-title":"Int J Cancer"},{"key":"R2-20250220","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cgh.2020.02.026","article-title":"Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location.","volume":"19","author":"Wong","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R3-20250220","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years.","volume":"30","author":"Sauer","year":"2012","journal-title":"J Clin Oncol"},{"key":"R4-20250220","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol"},{"key":"R5-20250220","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer.","volume":"355","author":"Bosset","year":"2006","journal-title":"N Engl J Med"},{"key":"R6-20250220","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/SLA.0b013e3181f3f1b1","article-title":"Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).","volume":"252","author":"Yeo","year":"2010","journal-title":"Ann Surg"},{"key":"R7-20250220","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1200\/JCO.2013.54.3769","article-title":"Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO\/ARO\/AIO-94 trial.","volume":"32","author":"Fokas","year":"2014","journal-title":"J Clin Oncol"},{"key":"R8-20250220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.23.00586","article-title":"International validation of the immunoscore biopsy in patients with rectal cancer managed by a watch-and-wait strategy.","volume":"42","author":"El Sissy","year":"2024","journal-title":"J Clin Oncol"},{"key":"R9-20250220","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clcc.2022.01.004","article-title":"Tumor-infiltrating PD-1+ immune cell density is associated with response to neoadjuvant chemoradiotherapy in rectal cancer.","volume":"21","author":"Kitagawa","year":"2022","journal-title":"Clin Colorectal Cancer"},{"key":"R10-20250220","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/bjs.11179","article-title":"Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer.","volume":"106","author":"Akiyoshi","year":"2019","journal-title":"Br J Surg"},{"key":"R11-20250220","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1016\/j.clcc.2020.04.002","article-title":"The effects of neoadjuvant treatment on the tumor microenvironment in rectal cancer: implications for immune activation and therapy response.","volume":"19","author":"Chen","year":"2020","journal-title":"Clin Colorectal Cancer"},{"key":"R12-20250220","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/jgh.15773","article-title":"Immune profile by multiplexed immunohistochemistry associated with recurrence after chemoradiation in rectal cancer.","volume":"37","author":"Hong","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"R13-20250220","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.radonc.2019.01.002","article-title":"Significance of perineural and lymphovascular invasion in locally advanced rectal cancer treated by preoperative chemoradiotherapy and radical surgery: can perineural invasion be an indication of adjuvant chemotherapy?","volume":"133","author":"Song","year":"2019","journal-title":"Radiother Oncol"},{"key":"R14-20250220","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/PAS.0000000000001272","article-title":"A multicenter study of the prognostic value of desmoplastic reaction categorization in stage II colorectal cancer.","volume":"43","author":"Ueno","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R15-20250220","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41416-020-01222-8","article-title":"Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a phase 3 study (SACURA Trial).","volume":"124","author":"Ueno","year":"2021","journal-title":"Br J Cancer"},{"key":"R16-20250220","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1245\/s10434-014-4149-9","article-title":"Histologic categorization of desmoplastic reaction: its relevance to the colorectal cancer microenvironment and prognosis.","volume":"22","author":"Ueno","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R17-20250220","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/gut.2003.028365","article-title":"Histological categorisation of fibrotic cancer stroma in advanced rectal cancer.","volume":"53","author":"Ueno","year":"2004","journal-title":"Gut"},{"key":"R18-20250220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1365-2559.2002.01376.x","article-title":"Clinicopathological significance of the \u2018keloid-like\u2019 collagen and myxoid stroma in advanced rectal cancer.","volume":"40","author":"Ueno","year":"2002","journal-title":"Histopathology"},{"key":"R19-20250220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2017.12.005","article-title":"Pattern of programmed cell death-ligand 1 expression and CD8-positive T-cell infiltration before and after chemoradiotherapy in rectal cancer.","volume":"91","author":"Ogura","year":"2018","journal-title":"Eur J Cancer"},{"key":"R20-20250220","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.clcc.2023.07.004","article-title":"Intratumoral budding and CD8-positive T-cell density in pretreatment biopsies as a predictor of response to neoadjuvant chemoradiotherapy in advanced rectal cancer.","volume":"22","author":"Sano","year":"2023","journal-title":"Clin Colorectal Cancer"},{"key":"R21-20250220","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/jjco\/hyab040","article-title":"Histopathological atlas of desmoplastic reaction characterization in colorectal cancer.","volume":"51","author":"Ueno","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"R22-20250220","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1097\/PAS.0000000000000946","article-title":"Desmoplastic pattern at the tumor front defines poor-prognosis subtypes of colorectal cancer.","volume":"41","author":"Ueno","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R23-20250220","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.surg.2017.09.007","article-title":"Disentangling the prognostic heterogeneity of stage III colorectal cancer through histologic stromal categorization.","volume":"163","author":"Ueno","year":"2018","journal-title":"Surgery"},{"key":"R24-20250220","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/PAS.0b013e318297ef6e","article-title":"Characterization of perineural invasion as a component of colorectal cancer staging.","volume":"37","author":"Ueno","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R25-20250220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s003840050072","article-title":"Pathological features of rectal cancer after preoperative radiochemotherapy.","volume":"12","author":"Dworak","year":"1997","journal-title":"Int J Colorectal Dis"},{"key":"R26-20250220","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics.","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R27-20250220","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00428-015-1756-1","article-title":"In rectal cancer, the type of desmoplastic response after preoperative chemoradiotherapy is associated with prognosis.","volume":"466","author":"Ueno","year":"2015","journal-title":"Virchows Arch"},{"key":"R28-20250220","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1245\/s10434-012-2327-1","article-title":"Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.","volume":"19","author":"Wolthuis","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R29-20250220","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/SLA.0000000000000368","article-title":"Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: a meta-analysis of published studies.","volume":"263","author":"Petrelli","year":"2016","journal-title":"Ann Surg"},{"key":"R30-20250220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ijc.2910530113","article-title":"Desmoplasia and its relevance to colorectal tumour invasion.","volume":"53","author":"Hewitt","year":"1993","journal-title":"Int J Cancer"},{"key":"R31-20250220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/cancers10090319","article-title":"Impact of tumor regression grade as a major prognostic factor in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a proposal for a modified staging system.","volume":"10","author":"Song","year":"2018","journal-title":"Cancers (Basel)"},{"key":"R32-20250220","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/SLA.0000000000002719","article-title":"Prognostic implications of pathological response to neoadjuvant chemoradiation in pathologic stage III rectal cancer.","volume":"269","author":"Karagkounis","year":"2019","journal-title":"Ann Surg"},{"key":"R33-20250220","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00268-018-4774-8","article-title":"Prognostic impact of perineural invasion in rectal cancer after neoadjuvant chemoradiotherapy.","volume":"43","author":"Kim","year":"2019","journal-title":"World J Surg"},{"key":"R34-20250220","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1470-2045(14)71199-4","article-title":"Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data.","volume":"16","author":"Breugom","year":"2015","journal-title":"Lancet Oncol"},{"key":"R35-20250220","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1200\/JCO.2007.11.9685","article-title":"Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.","volume":"25","author":"Collette","year":"2007","journal-title":"J Clin Oncol"},{"key":"R36-20250220","doi-asserted-by":"crossref","first-page":"108001","DOI":"10.1016\/j.ejso.2024.108001","article-title":"The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: insights from ypT stage.","volume":"50","author":"Cai","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"R37-20250220","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1186\/s12885-019-6261-5","article-title":"Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy.","volume":"19","author":"Trotsyuk","year":"2019","journal-title":"BMC Cancer"}],"container-title":["Diseases of the Colon &amp; Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DCR.0000000000003589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T20:00:34Z","timestamp":1740081634000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DCR.0000000000003589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dcr.0000000000003589","relation":{},"ISSN":["0012-3706","1530-0358"],"issn-type":[{"value":"0012-3706","type":"print"},{"value":"1530-0358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]}}}